Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Frazier Life Sciences

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 25
Average round size
info
The average size of a deal this fund participated in
$91M
Portfolio companies 22
Rounds per year 0.76
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 11
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Biopharma

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sudo Biosciences

Biopharma
$30M13 Feb 2024 Menlo Park, California, United States

Radionetics Oncology

Pharmaceutical
Therapeutics
$52M03 Jan 2024 California City, California, United States

Sudo Biosciences

Biopharma
$116M20 Dec 2023 Menlo Park, California, United States

Lassen Therapeutics

Biotechnology
Life Science
$85M19 Dec 2023 San Diego, California, United States

Radionetics Oncology

Pharmaceutical
Therapeutics
$52M14 Aug 2023 California City, California, United States

Attovia Therapeutics

Biotechnology
Health Care
Medical
$60M20 Jun 2023 Fremont, California, United States

Alpha9 Theranostics

Biotechnology
Medical
Product Research
$75M14 Dec 2022 Vancouver, British Columbia, Canada

MBX Biosciences

Biotechnology
Health Care
Wellness
$115M14 Nov 2022 Indiana, United States

Enlaza Therapeutics

Biopharma
Biotechnology
Health Care
Therapeutics
$61M12 Oct 2022 La Jolla, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Frazier Life Sciences?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 25
Average round size 91M
Rounds per year 0.76
Peak activity year 2023
Lead investments 3
Follow on index 0.12
Exits 11
Group Appearance index 0.96

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Sudo Biosciences

Biopharma
$30M13 Feb 2024 Menlo Park, California, United States

Radionetics Oncology

Pharmaceutical
Therapeutics
$52M03 Jan 2024 California City, California, United States

Sudo Biosciences

Biopharma
$116M20 Dec 2023 Menlo Park, California, United States

Lassen Therapeutics

Biotechnology
Life Science
$85M19 Dec 2023 San Diego, California, United States

Radionetics Oncology

Pharmaceutical
Therapeutics
$52M14 Aug 2023 California City, California, United States

Attovia Therapeutics

Biotechnology
Health Care
Medical
$60M20 Jun 2023 Fremont, California, United States

Alpha9 Theranostics

Biotechnology
Medical
Product Research
$75M14 Dec 2022 Vancouver, British Columbia, Canada

MBX Biosciences

Biotechnology
Health Care
Wellness
$115M14 Nov 2022 Indiana, United States

Enlaza Therapeutics

Biopharma
Biotechnology
Health Care
Therapeutics
$61M12 Oct 2022 La Jolla, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: